C
Chris J.L.M. Meijer
Researcher at VU University Amsterdam
Publications - 745
Citations - 83366
Chris J.L.M. Meijer is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Cervical cancer & Cervical intraepithelial neoplasia. The author has an hindex of 128, co-authored 733 publications receiving 78705 citations. Previous affiliations of Chris J.L.M. Meijer include VU University Medical Center & Academic Center for Dentistry Amsterdam.
Papers
More filters
Book ChapterDOI
Primary Screening by Human Papillomavirus Testing: Development, Implementation, and Perspectives
TL;DR: Different collection techniques of cervicovaginal material for HPV and triage testing are highlighted, including self-sampling, different triage tests to select HPV positive women for colposcopy referral, and developments, which may result into full molecular self-screening.
Journal ArticleDOI
Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening
Daniëlle A.M. Heideman,Anja Oštrbenk Valenčak,Saskia Doorn,Jesper Bonde,Peter Hillemanns,Grega Gimpelj Domjanič,Jana Mlakar,Albertus T. Hesselink,Chris J.L.M. Meijer,Mario Poljak +9 more
TL;DR: The NeuMoDx HPV assay meets international guideline criteria for cross-sectional accuracy and reproducibility, and performs equally well on cervical screening specimens collected in two widely used collection media.
Journal ArticleDOI
Posttreatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3
Frederique J Vink,Renske D.M. Steenbergen,Wieke W. Kremer,Birgit I. Lissenberg-Witte,Daniëlle A.M. Heideman,Maaike C G Bleeker,Marjolein van Zummeren,Erika Breytenbach,Cathy Visser,Azwidowi Lukhwareni,Chris J.L.M. Meijer,Greta Dreyer +11 more
TL;DR: A negative ASCL1/LHX8 methylation test in follow-up is associated with a low rCIN2/3 risk and could serve as an objective test of cure and well tolerated alternative for HPV and/or cytology screening in the posttreatment monitoring of WWH.
Journal ArticleDOI
Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse in HPV-Positive Women with Normal Cytology and Five-Year Type Concordance: A Randomized Comparison.
Federica Inturrisi,Johannes A. Bogaards,Johannes A. Bogaards,Daniëlle A M Heideman,Chris J.L.M. Meijer,Johannes Berkhof +5 more
TL;DR: Five-year HPV type concordance signals high CIN3+ risk and warrants referral for colposcopy without additional cytology triage, and HPV screening programs become highly efficient when HPV-positive women with negative triage testing at baseline are offered repeat HPV genotyping after five years.